Dynavax Technologies Corp
NASDAQ:DVAX

Watchlist Manager
Dynavax Technologies Corp Logo
Dynavax Technologies Corp
NASDAQ:DVAX
Watchlist
Price: 13.5 USD -1.17% Market Closed
Market Cap: 1.8B USD
Have any thoughts about
Dynavax Technologies Corp?
Write Note

Dynavax Technologies Corp
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dynavax Technologies Corp
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Dynavax Technologies Corp
NASDAQ:DVAX
Accrued Liabilities
$57.6m
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
17%
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$14.6B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.5B
CAGR 3-Years
7%
CAGR 5-Years
25%
CAGR 10-Years
24%

See Also

What is Dynavax Technologies Corp's Accrued Liabilities?
Accrued Liabilities
57.6m USD

Based on the financial report for Jun 30, 2024, Dynavax Technologies Corp's Accrued Liabilities amounts to 57.6m USD.

What is Dynavax Technologies Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
17%

Over the last year, the Accrued Liabilities growth was 38%. The average annual Accrued Liabilities growth rates for Dynavax Technologies Corp have been 20% over the past three years , 17% over the past five years , and 17% over the past ten years .

Back to Top